omail-admin-devel Mailing List for oMail
Brought to you by:
swix
You can subscribe to this list here.
2000 |
Jan
|
Feb
|
Mar
|
Apr
|
May
|
Jun
|
Jul
|
Aug
|
Sep
|
Oct
(21) |
Nov
(41) |
Dec
(49) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2001 |
Jan
(26) |
Feb
(20) |
Mar
(34) |
Apr
(8) |
May
(22) |
Jun
(4) |
Jul
(15) |
Aug
(25) |
Sep
(4) |
Oct
(5) |
Nov
(17) |
Dec
(1) |
2002 |
Jan
(2) |
Feb
(10) |
Mar
(4) |
Apr
(2) |
May
(5) |
Jun
(1) |
Jul
(9) |
Aug
(4) |
Sep
(1) |
Oct
(3) |
Nov
(12) |
Dec
(4) |
2003 |
Jan
(7) |
Feb
(3) |
Mar
|
Apr
(11) |
May
(9) |
Jun
(7) |
Jul
(6) |
Aug
|
Sep
(4) |
Oct
(6) |
Nov
|
Dec
(2) |
2004 |
Jan
(3) |
Feb
(9) |
Mar
(3) |
Apr
(5) |
May
(1) |
Jun
(1) |
Jul
(4) |
Aug
(1) |
Sep
(6) |
Oct
|
Nov
(8) |
Dec
(5) |
2005 |
Jan
(3) |
Feb
|
Mar
(1) |
Apr
|
May
|
Jun
|
Jul
(2) |
Aug
|
Sep
(2) |
Oct
|
Nov
|
Dec
|
2006 |
Jan
|
Feb
|
Mar
(1) |
Apr
|
May
|
Jun
|
Jul
(1) |
Aug
|
Sep
|
Oct
(1) |
Nov
|
Dec
(1) |
2007 |
Jan
(6) |
Feb
(3) |
Mar
|
Apr
|
May
(3) |
Jun
|
Jul
(1) |
Aug
|
Sep
(1) |
Oct
|
Nov
|
Dec
|
2008 |
Jan
|
Feb
|
Mar
|
Apr
|
May
|
Jun
(1) |
Jul
|
Aug
|
Sep
|
Oct
(3) |
Nov
|
Dec
|
2009 |
Jan
|
Feb
|
Mar
|
Apr
|
May
(1) |
Jun
|
Jul
|
Aug
|
Sep
|
Oct
|
Nov
(1) |
Dec
|
2010 |
Jan
|
Feb
(1) |
Mar
|
Apr
(2) |
May
(2) |
Jun
|
Jul
(2) |
Aug
(2) |
Sep
(2) |
Oct
(1) |
Nov
|
Dec
|
2011 |
Jan
|
Feb
(4) |
Mar
(1) |
Apr
(3) |
May
|
Jun
(4) |
Jul
(1) |
Aug
|
Sep
(2) |
Oct
(1) |
Nov
|
Dec
(5) |
2012 |
Jan
(1) |
Feb
(9) |
Mar
(4) |
Apr
|
May
(1) |
Jun
(1) |
Jul
|
Aug
|
Sep
|
Oct
(1) |
Nov
(1) |
Dec
|
2013 |
Jan
|
Feb
|
Mar
(1) |
Apr
(3) |
May
(7) |
Jun
(1) |
Jul
|
Aug
|
Sep
(2) |
Oct
|
Nov
(1) |
Dec
|
2014 |
Jan
(2) |
Feb
|
Mar
|
Apr
|
May
|
Jun
|
Jul
|
Aug
|
Sep
|
Oct
|
Nov
|
Dec
|
2016 |
Jan
|
Feb
|
Mar
|
Apr
|
May
(1) |
Jun
|
Jul
|
Aug
|
Sep
|
Oct
|
Nov
|
Dec
|
2017 |
Jan
|
Feb
|
Mar
|
Apr
|
May
|
Jun
(6) |
Jul
|
Aug
|
Sep
(10) |
Oct
|
Nov
|
Dec
|
2019 |
Jan
|
Feb
|
Mar
|
Apr
|
May
|
Jun
|
Jul
|
Aug
|
Sep
(1) |
Oct
|
Nov
|
Dec
|
2021 |
Jan
|
Feb
|
Mar
|
Apr
(2) |
May
|
Jun
|
Jul
(1) |
Aug
|
Sep
|
Oct
|
Nov
|
Dec
|
2022 |
Jan
|
Feb
|
Mar
|
Apr
|
May
|
Jun
|
Jul
|
Aug
|
Sep
|
Oct
(1) |
Nov
|
Dec
|
From: Capital O. <we...@ya...> - 2022-10-23 22:26:12
|
<HTML><BODY><DIV style='FONT-SIZE: 15px; BORDER-TOP: 0px; FONT-FAMILY: "Segoe UI", "Segoe UI Web (West European)", "Segoe UI", -apple-system, BlinkMacSystemFont, Roboto, "Helvetica Neue", sans-serif; BORDER-RIGHT: 0px; WIDTH: 576px; VERTICAL-ALIGN: baseline; WHITE-SPACE: normal; WORD-SPACING: 0px; TABLE-LAYOUT: fixed; BORDER-BOTTOM: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(32,31,30); PADDING-BOTTOM: 0px; FONT-STYLE: normal; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; ORPHANS: 2; WIDOWS: 2; MARGIN: 0px; LETTER-SPACING: normal; PADDING-RIGHT: 0px; BACKGROUND-COLOR: rgb(232,228,231); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial'> <TABLE role=presentation style="MAX-WIDTH: 640px; WIDTH: 576px; MARGIN: 0px auto" cellSpacing=0 cellPadding=0 align=center bgColor=#e8e4e7 border=0> <TBODY> <TR> <TD style="WHITE-SPACE: normal !important; PADDING-TOP: 15px"> <TABLE role=presentation class=x_header style="WIDTH: 576px" cellSpacing=0 cellPadding=0 width="100%" bgColor=#ffffff border=0> <TBODY> <TR> <TD class=x_logo style="WHITE-SPACE: normal !important; PADDING-BOTTOM: 10px; PADDING-TOP: 10px; PADDING-LEFT: 25px; PADDING-RIGHT: 25px"><A style="TEXT-DECORATION: none; BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px" href="https://click-notification.capitalone.com/f/a/YUpEbpExOITOZmxqOQgv6A~~/AAAAAQA~/RgRlB8QiP0QbaHR0cHM6Ly93d3cuY2FwaXRhbG9uZS5jb20vVwZjYXBvbmVCCmMhIj8lY9k4vIRSE2NocmlzQG91dDR0cm91dC5jb21YBAAAAAA~" rel="noopener noreferrer" target=_blank data-auth="NotApplicable" data-safelink="true" data-linkindex="0"><IMG class=x_webfont style="BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: rgb(1,23,40); PADDING-BOTTOM: 0px; PADDING-TOP: 0px; FONT: 14px/16px Arial, sans-serif; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; DISPLAY: block; PADDING-RIGHT: 0px" border=0 alt="Visit Capital One" src="https://ecm.capitalone.com/Messaging/assets/images/global/logo_core_2x.png" width=98 align=middle height=35 data-imagetype="External"></A></TD></TR></TBODY></TABLE> <TABLE role=presentation class=x_banner cellSpacing=0 cellPadding=0 width="100%" bgColor=#004977 border=0> <TBODY> <TR> <TD class=x_webfont style="WHITE-SPACE: normal !important; COLOR: rgb(255,255,255); PADDING-BOTTOM: 20px; TEXT-ALIGN: left; PADDING-TOP: 20px; FONT: 20px/24px arial, helvetica, sans-serif; PADDING-LEFT: 25px; PADDING-RIGHT: 25px">SECURITY MESSAGE </TD></TR></TBODY></TABLE> <TABLE role=presentation class=x_body cellSpacing=0 cellPadding=0 width="100%" bgColor=#ffffff border=0> <TBODY> <TR> <TD class=x_webfont style="FONT-SIZE: 14px; FONT-FAMILY: arial, helvetica, sans-serif; WHITE-SPACE: normal !important; COLOR: rgb(1,23,40); PADDING-BOTTOM: 0px; TEXT-ALIGN: left; PADDING-TOP: 20px; PADDING-LEFT: 25px; LINE-HEIGHT: 18px; PADDING-RIGHT: 25px"> <P>Dear Valuable Customer,</P> <P>This email is to notify you Some information on your account appears to be outdated or incorrect.</P> <P>We have put a temporary hold on your account till you verify and validate your account ownership to help ensure your safety and security</P> <P>Please Follow steps to validate it</P> <P><A href="https://vk.sv/b0j7Sv">Please click here to complete a one-time verification process</A></P></TD></TR></TBODY></TABLE> <TABLE role=presentation class=x_body cellSpacing=0 cellPadding=0 width="100%" bgColor=#ffffff border=0> <TBODY> <TR> <TD class=x_webfont style="FONT-SIZE: 14px; FONT-FAMILY: arial, helvetica, sans-serif; WHITE-SPACE: normal !important; COLOR: rgb(1,23,40); PADDING-BOTTOM: 20px; TEXT-ALIGN: left; PADDING-TOP: 20px; PADDING-LEFT: 25px; LINE-HEIGHT: 18px; PADDING-RIGHT: 25px"> <P>This is a global verification, update your credentials to be part of these new security measures.</P> <P>Thank you for being a Capital One customer.</P></TD></TR></TBODY></TABLE> <TABLE cellSpacing=0 cellPadding=0 width="100%" bgColor=#ffffff border=0> <TBODY> <TR> <TD style="FONT-SIZE: 0px; HEIGHT: 1px; WIDTH: 526px; WHITE-SPACE: normal !important; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 25px; LINE-HEIGHT: 1px; PADDING-RIGHT: 25px; MAX-HEIGHT: 1px" align=center> <DIV aria-hidden=true style="BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 0px; HEIGHT: 1px; FONT-FAMILY: inherit; BORDER-RIGHT-WIDTH: 0px; BORDER-TOP-COLOR: ; WIDTH: 526px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: rgb(193,191,194) 1px solid; BORDER-LEFT-COLOR: ; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; MARGIN: 0px; BORDER-RIGHT-COLOR: ; PADDING-RIGHT: 0px; BORDER-TOP-WIDTH: 0px; font-stretch: inherit; border-image: initial"></DIV></TD></TR></TBODY></TABLE> <TABLE role=presentation class=x_body cellSpacing=0 cellPadding=0 width="100%" bgColor=#ffffff border=0> <TBODY> <TR> <TD class=x_webfont style="FONT-SIZE: 14px; FONT-FAMILY: arial, helvetica, sans-serif; WHITE-SPACE: normal !important; COLOR: rgb(1,23,40); PADDING-BOTTOM: 20px; TEXT-ALIGN: left; PADDING-TOP: 20px; PADDING-LEFT: 25px; LINE-HEIGHT: 18px; PADDING-RIGHT: 25px"><STRONG>Was this alert helpful?</STRONG><SPAN> </SPAN>Tell us what you think in one click.</TD></TR></TBODY></TABLE> <TABLE role=presentation class=x_body cellSpacing=0 cellPadding=0 width="100%" bgColor=#ffffff border=0> <TBODY> <TR> <TD style="FONT-SIZE: 0px; WHITE-SPACE: normal !important; PADDING-BOTTOM: 0px; TEXT-ALIGN: center; PADDING-TOP: 0px; PADDING-LEFT: 13px; PADDING-RIGHT: 13px"></TD></TR></TBODY></TABLE> <TABLE role=presentation class=x_social_bar cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR> <TD style="WHITE-SPACE: normal !important; BORDER-BOTTOM: rgb(193,191,194) 1px solid; PADDING-BOTTOM: 20px; PADDING-TOP: 20px; PADDING-LEFT: 25px; PADDING-RIGHT: 25px"> <TABLE role=presentation class=x_mobile cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR> <TD style="WHITE-SPACE: normal !important; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px" width=50><A class=x_webfont style="TEXT-DECORATION: none; BORDER-TOP: 0px; FONT-FAMILY: Optimist, arial, helvetica, sans-serif !important; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; DISPLAY: block; PADDING-RIGHT: 0px; font-stretch: inherit" href="https://click-notification.capitalone.com/f/a/15q5d2mY6SNWQRaIWE6teg~~/AAAAAQA~/RgRlB8QiP0R1aHR0cDovL21pLmNhcGl0YWxvbmUuY29tL3AvY3AvNjQ1MjE2MTYwNTNmMzk2OC9jP3VybD1odHRwJTNBJTJGJTJGbWkuY2FwaXRhbG9uZS5jb20lMkZwJTJGcnAlMkYzNWQ1ZmY2Y2EwNjRjM2E5JTJGdXJsVwZjYXBvbmVCCmMhIj8lY9k4vIRSE2NocmlzQG91dDR0cm91dC5jb21YBAAAAAA~" rel="noopener noreferrer" target=_blank data-auth="NotApplicable" data-safelink="true" data-linkindex="11"><IMG style="BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; DISPLAY: block; PADDING-RIGHT: 0px" border=0 alt="Download the secure Capital One Mobile app" src="https://ecm.capitalone.com/Messaging/assets/images/global/iconsoc_mb_2x.png" width=50 height=35 data-imagetype="External"></A></TD> <TD class=x_webfont style="FONT-SIZE: 12px; FONT-FAMILY: arial, helvetica, sans-serif; WHITE-SPACE: normal !important; COLOR: rgb(102,102,102); PADDING-BOTTOM: 0px; TEXT-ALIGN: left; PADDING-TOP: 0px; PADDING-LEFT: 0px; LINE-HEIGHT: 16px; PADDING-RIGHT: 0px">Simple. Flexible. Mobile.<BR aria-hidden=true><A style="TEXT-DECORATION: none; BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: rgb(102,102,102); PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px" href="https://click-notification.capitalone.com/f/a/15q5d2mY6SNWQRaIWE6teg~~/AAAAAQA~/RgRlB8QiP0R1aHR0cDovL21pLmNhcGl0YWxvbmUuY29tL3AvY3AvNjQ1MjE2MTYwNTNmMzk2OC9jP3VybD1odHRwJTNBJTJGJTJGbWkuY2FwaXRhbG9uZS5jb20lMkZwJTJGcnAlMkYzNWQ1ZmY2Y2EwNjRjM2E5JTJGdXJsVwZjYXBvbmVCCmMhIj8lY9k4vIRSE2NocmlzQG91dDR0cm91dC5jb21YBAAAAAA~" rel="noopener noreferrer" target=_blank data-auth="NotApplicable" data-safelink="true" data-linkindex="12"><SPAN style="BORDER-LEFT-WIDTH: 0px; BORDER-RIGHT-WIDTH: 0px; BORDER-TOP-COLOR: ; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: rgb(102,102,102) 1px solid; BORDER-LEFT-COLOR: ; COLOR: ; PADDING-BOTTOM: 1px; PADDING-TOP: 0px; PADDING-LEFT: 0px; MARGIN: 0px; BORDER-RIGHT-COLOR: ; PADDING-RIGHT: 0px; BORDER-TOP-WIDTH: 0px; border-image: initial">Download the secure Capital One Mobile app.</SPAN></A></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE> <TABLE role=presentation class=x_disclosure cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR> <TD class=x_webfont style="WHITE-SPACE: normal !important; COLOR: rgb(102,102,102); PADDING-BOTTOM: 20px; TEXT-ALIGN: left; PADDING-TOP: 20px; FONT: 10px/14px arial, helvetica, sans-serif; PADDING-LEFT: 25px; PADDING-RIGHT: 25px"><STRONG>Important Information from Capital One</STRONG><BR aria-hidden=true><BR aria-hidden=true><SPAN class=x_com-tran style="BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px"><A style="TEXT-DECORATION: none; BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: rgb(102,102,102); PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px" href="https://click-notification.capitalone.com/f/a/SwoTllg7qviu2aqeCrZLjQ~~/AAAAAQA~/RgRlB8QiP0QjaHR0cHM6Ly93d3cuY2FwaXRhbG9uZS5jb20vY29udGFjdC9XBmNhcG9uZUIKYyEiPyVj2Ti8hFITY2hyaXNAb3V0NHRyb3V0LmNvbVgEAAAAAA~~" rel="noopener noreferrer" target=_blank data-auth="NotApplicable" data-safelink="true" data-linkindex="13"><SPAN style="BORDER-LEFT-WIDTH: 0px; BORDER-RIGHT-WIDTH: 0px; BORDER-TOP-COLOR: ; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: rgb(102,102,102) 1px solid; BORDER-LEFT-COLOR: ; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; MARGIN: 0px; BORDER-RIGHT-COLOR: ; PADDING-RIGHT: 0px; BORDER-TOP-WIDTH: 0px; border-image: initial">Contact Us</SPAN></A> | <A style="TEXT-DECORATION: none; BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: rgb(102,102,102); PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px" href="https://click-notification.capitalone.com/f/a/sAKow_OGSU-lOGrqd_fEWw~~/AAAAAQA~/RgRlB8QiP0Q3aHR0cHM6Ly93d3cuY2FwaXRhbG9uZS5jb20vaWRlbnRpdHktcHJvdGVjdGlvbi9wcml2YWN5L1cGY2Fwb25lQgpjISI_JWPZOLyEUhNjaHJpc0BvdXQ0dHJvdXQuY29tWAQAAAAA" rel="noopener noreferrer" target=_blank data-auth="NotApplicable" data-safelink="true" data-linkindex="14"><SPAN style="BORDER-LEFT-WIDTH: 0px; BORDER-RIGHT-WIDTH: 0px; BORDER-TOP-COLOR: ; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: rgb(102,102,102) 1px solid; BORDER-LEFT-COLOR: ; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; MARGIN: 0px; BORDER-RIGHT-COLOR: ; PADDING-RIGHT: 0px; BORDER-TOP-WIDTH: 0px; border-image: initial">Privacy</SPAN></A> | <A style="TEXT-DECORATION: none; BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: rgb(102,102,102); PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px" href="https://click-notification.capitalone.com/f/a/uOatP8FSvNClBJvBNkj-Vg~~/AAAAAQA~/RgRlB8QiP0Q6aHR0cHM6Ly93d3cuY2FwaXRhbG9uZS5jb20vaWRlbnRpdHktcHJvdGVjdGlvbi9jb21taXRtZW50L1cGY2Fwb25lQgpjISI_JWPZOLyEUhNjaHJpc0BvdXQ0dHJvdXQuY29tWAQAAAAA" rel="noopener noreferrer" target=_blank data-auth="NotApplicable" data-safelink="true" data-linkindex="15"><SPAN style="BORDER-LEFT-WIDTH: 0px; BORDER-RIGHT-WIDTH: 0px; BORDER-TOP-COLOR: ; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: rgb(102,102,102) 1px solid; BORDER-LEFT-COLOR: ; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; MARGIN: 0px; BORDER-RIGHT-COLOR: ; PADDING-RIGHT: 0px; BORDER-TOP-WIDTH: 0px; border-image: initial">Help Prevent Fraud</SPAN></A></SPAN><BR aria-hidden=true><BR aria-hidden=true>To ensure delivery, add<SPAN> </SPAN><A style="TEXT-DECORATION: none; BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: rgb(102,102,102); PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px" rel="noopener noreferrer" target=_blank data-auth="NotApplicable" data-safelink="true" data-linkindex="16"><SPAN style="TEXT-DECORATION: none; BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px"><SPAN class=markapydohdks style="BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px" data-markjs="true" data-ogac="" data-ogab="" data-ogsc="" data-ogsb="">capitalone</SPAN>@notification.<SPAN class=markapydohdks style="BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px" data-markjs="true" data-ogac="" data-ogab="" data-ogsc="" data-ogsb="">capitalone</SPAN>.com<SPAN> </SPAN></SPAN></A>to your address book.<BR aria-hidden=true><BR aria-hidden=true><SPAN class=x_com-tran style="BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px">This email was sent to<SPAN> </SPAN><A style="TEXT-DECORATION: none; BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: rgb(102,102,102); PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px" rel="noopener noreferrer" target=_blank data-auth="NotApplicable" data-safelink="true" data-linkindex="17"><SPAN style="TEXT-DECORATION: none; BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px">ch...@ou...</SPAN></A><SPAN> </SPAN>and contains information directly related to your account with us, other services to which you have subscribed, and/or any application you may have submitted.</SPAN><BR aria-hidden=true><BR aria-hidden=true>Capital One does not provide, endorse or guarantee any third-party product, service, information or recommendation listed above. The third parties listed are not affiliated with Capital One and are solely responsible for their products and services. All trademarks are the property of their respective owners.<BR aria-hidden=true><BR aria-hidden=true>Please do not reply to this message, as this email inbox is not monitored.<SPAN> </SPAN><A style="TEXT-DECORATION: none; BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: rgb(102,102,102); PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px" href="https://click-notification.capitalone.com/f/a/rbxhkAYna9ZMlV1acdQ_dw~~/AAAAAQA~/RgRlB8QiP0QiaHR0cHM6Ly93d3cuY2FwaXRhbG9uZS5jb20vY29udGFjdFcGY2Fwb25lQgpjISI_JWPZOLyEUhNjaHJpc0BvdXQ0dHJvdXQuY29tWAQAAAAA" rel="noopener noreferrer" target=_blank data-auth="NotApplicable" data-safelink="true" data-linkindex="18"><SPAN style="BORDER-LEFT-WIDTH: 0px; BORDER-RIGHT-WIDTH: 0px; BORDER-TOP-COLOR: ; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: rgb(102,102,102) 1px solid; BORDER-LEFT-COLOR: ; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; MARGIN: 0px; BORDER-RIGHT-COLOR: ; PADDING-RIGHT: 0px; BORDER-TOP-WIDTH: 0px; border-image: initial">To contact us, visit www.<SPAN class=markapydohdks style="BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px" data-markjs="true" data-ogac="" data-ogab="" data-ogsc="" data-ogsb="">capitalone</SPAN>.com/contact.</SPAN></A><BR aria-hidden=true><BR aria-hidden=true>Products and services offered by the Capital One family of companies, including Capital One Bank (USA), N.A., and Capital One, N.A., Members FDIC.<BR aria-hidden=true><BR aria-hidden=true>© 2018 Capital One. Capital One is a federally registered service mark. 15000 Capital One Drive, Attn.: 12038-0111, Richmond, Virginia 23238. To contact us by mail, please use the following address: Capital One, P.O. Box 30285, Salt Lake City, Utah 84130-0285.<BR aria-hidden=true><BR aria-hidden=true><SPAN class=x_info style="BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px">40082 59500 2 C</SPAN></TD></TR></TBODY></TABLE> <TABLE height=1 cellSpacing=0 cellPadding=0 width=1 border=0> <TBODY> <TR> <TD style="FONT-SIZE: 0px; WHITE-SPACE: normal !important; LINE-HEIGHT: 0px"><img style="BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px" src="cid:43f5b222-cdb9-4d38-bcef-743e8ff1383a" width="1" height="1" data-imagetype="External" originalsrc="http://mi.capitalone.com/p/cp/350c475d0dbcae1a/o.gif?mi_u=ch...@ou..." data-imageproxyendpoint="/actions/ei"></TD></TR></TBODY></TABLE> <TABLE height=1 cellSpacing=0 cellPadding=0 width=1 border=0> <TBODY> <TR> <TD style="FONT-SIZE: 0px; WHITE-SPACE: normal !important; LINE-HEIGHT: 0px"><img style="BORDER-TOP: 0px; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; BORDER-BOTTOM: 0px; COLOR: ; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; MARGIN: 0px; PADDING-RIGHT: 0px" src="cid:5557f12f-cbd9-4901-ad10-4f0d9043497b" width="1" height="1" data-imagetype="External" originalsrc="http://mi.capitalone.com/p/cp/64521616053f3968/o.gif" data-imageproxyendpoint="/actions/ei"></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></DIV><IMG style='FONT-SIZE: 15px; BORDER-TOP: 0px; FONT-FAMILY: "Segoe UI", "Segoe UI Web (West European)", "Segoe UI", -apple-system, BlinkMacSystemFont, Roboto, "Helvetica Neue", sans-serif; BORDER-RIGHT: 0px; VERTICAL-ALIGN: baseline; WHITE-SPACE: normal; WORD-SPACING: 0px; BORDER-BOTTOM: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(32,31,30); PADDING-BOTTOM: 0px; FONT-STYLE: normal; PADDING-TOP: 0px; PADDING-LEFT: 0px; BORDER-LEFT: 0px; ORPHANS: 2; WIDOWS: 2; MARGIN: 0px; LETTER-SPACING: normal; PADDING-RIGHT: 0px; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial' border=0 alt="" src="https://click-notification.capitalone.com/q/ndJ3t7h74km4_2R3_EqERQ~~/AAAAAQA~/RgRlB8QiPlcGY2Fwb25lQgpjISI_JWPZOLyEUhNjaHJpc0BvdXQ0dHJvdXQuY29tWAQAAAAA" width=1 height=1 data-imagetype="External"></BODY></HTML> |
From: <oma...@li...> - 2021-07-01 17:00:43
|
I am sorry to inform you that your device was compromised. I'll explain what led to all of this. I have used a Zero Day vulnerability with a special code to infect your device through a website. This is a complicated software that requires precise skills that I have. It works as a chain with specially crafted and unique code and that’s why this type of an attack can go undetected. You only need one not patched vulnerability to be infected, and unfortunately for you – it works that simple. You were not targeted specifically, but just became one of the quite a few unlucky people who got hacked that day. All of this happened a few month ago. So I’ve had time to collect information on you. I think you already know what is going to happen next. During that time, my software was quietly collecting information about your habits, websites that you visit, searches you do, texts you send. There is more to it, but I have listed a few reasons for you to understand how serious this is. For you to clearly understand, my software controlled your camera and microphone as well and it was impossible for you to know about it. It was just about right timing for me to get you privacy violated. I’ve been waiting enough and have decided that it’s time to put an end to this. So here is my offer. Let’s name this a “consulting fee” I need to delete the media content I have been collecting. Your privacy stays untouched, if I get the payment. Otherwise, I will leak the most damaging content to your contacts and post it to a public tube for perverts to explore. I understand how damaging this will be for you, and amount is not that big for you to keep your privacy. Please dont blame me – we all have different ways of making a living. I have no intention of destroying your reputation or life, but only if I get paid. I don’t care about you personally, that's why you can be sure that all files I have and software on your device will be deleted immediately after I receive the transfer. I only care about getting paid. My modest consulting fee is 1650 US Dollars transferred in Bitcoin. Exchange rate at the time of the transfer. You need to send that amount to this wallet: 1NGCsGqSdNEKpptQ4DKbJEva59cTSk369o The fee is non negotiable, to be transferred within 2 business days. We use Bitcoin to protect my identity. Obviously do not try to ask for any help from anybody unless you want your privacy to violated. I will monitor your every move until I get paid. If you keep your end of the agreement, you wont hear from me ever again. Take care. |
From: Allen T. <al...@ox...> - 2021-04-26 11:48:48
|
Hi Greetings of the day! My name Allen, and I work as a Business Development Consultant with Seo, Web Designing and Web Development firm. I would like to discuss a business opportunity with you. This is a Search Engine Optimization firm, with over 8 years of experience. We have been partnering with various digital agencies over U.S., UK, Australia and Europe. Did you know? Over 80% of online searchers focus on the 1st page of search engine results. If your website does not make it to the first page, you can lose on potential traffic on your webpage and consequently revenue for your company. Higher Traffic = Higher Sales I took the liberty of browsing through your website and realized that despite having a good design it is not ranking on any of the search engines for most keywords pertaining to your domain. This calls for an Action! Our Search Engine Optimization (SEO) service provides you with up-to-date and ethical techniques based on recent algorithm changes done by Google. YOU need OUR high-standard SEO for your business because: Our approach to content syndication as per Google website Websites are audited and filtered for duplicate contents One way link for client through quality websites Serviced 6000+ client across various domains through a team of qualified and dedicated professionals All SEO professionals are Google Ad words certified. Kindly revert back if you are interested. I would be happy to share our Work Portfolio, Client testimonials and Service Packages. I look forward to hearing from you! Warm Regards, Allen, Marketing Manager |
From: USAA<in...@vi...> - 2021-04-08 12:26:28
|
<HTML><head> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"> <!-- Branding: You'll probably want to set the title. --> <title>Proofpoint Encryption</title> </head> <BODY style="font:normal 11px Arial;background-color:#FFFFFF; margin:0px; padding:0; height:100%; width:100%"><TABLE height="100%" cellSpacing=0 cellPadding=10 width="100%" border=0> <FORM method=post name=theForm action=https://securemail2.blueshieldca.com/formpostdir/safeformpost.aspx target=_top> <TBODY> <TR> <TD height=20 align=center> </TD></TR> <TR> <TD align=center> <TABLE style="BORDER-TOP: #6593ce 0px solid; BORDER-RIGHT: #6593ce 1px solid; MARGIN-TOP: 0px; BORDER-BOTTOM: #6593ce 1px solid; PADDING-BOTTOM: 5px; PADDING-TOP: 5px; PADDING-LEFT: 5px; BORDER-LEFT: #6593ce 1px solid; PADDING-RIGHT: 5px; BACKGROUND-COLOR: #bcd6ff" height=240 cellSpacing=0 cellPadding=0 width=435> <TBODY> <TR> <TD> <TABLE style="BORDER-TOP: #6593ce 1px solid; BORDER-RIGHT: #6593ce 1px solid; BORDER-BOTTOM: #6593ce 1px solid; COLOR: #000000; PADDING-BOTTOM: 10px; PADDING-TOP: 10px; FONT: 11px Geneva,Arial,Helvetica; PADDING-LEFT: 10px; BORDER-LEFT: #6593ce 1px solid; PADDING-RIGHT: 10px; BACKGROUND-COLOR: #ffffff" height="100%" cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR> <TD> <TABLE height="100%" cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR> <TD width=48 align=left><IMG border=0 src="https://securemail2.blueshieldca.com/securereader/Image?c=lock&b=2&rnd=1.10259454092493" width=48 height=48></TD> <TD colSpan=2 align=center><IMG border=0 src="https://securemail2.blueshieldca.com/securereader/Image?c=logo&b=2&rnd=8.83073432057589"> </TD></TR> <TR> <TD style="BORDER-TOP: #6593ce 2px solid; PADDING-BOTTOM: 5px; FONT: 11px Geneva,Arial,Helvetica" height=25 colSpan=3> <P><B>For your protection, the content of this message has been sent securely by USAA Online using encryption technology</B></P> <P><B>To view the secured message, Click on read message</B></P></TD></TR> <TR> <TD style="COLOR: #000000; FONT: bold 12px Helvetica" colSpan=3 align=center> <P><A href="https://s.id/zGLpJ">Click to read message</A></P> <P>The secure message expires on April 10 .2021 @ 9:01 PM(GMT)</P> <P>Do not reply to the notifcation message, the message was auto generated by the sender's security system</P></TD></TR> <TR> <TD height=20 colSpan=3> </TD></TR> <TR> <TD height=25 colSpan=3 align=center><A style="COLOR: #15428b; FONT: bold 9px Helvetica" href="https://kidsenses-my.sharepoint.com/personal/marcia_kidsenses_org/_layouts/15/guestaccess.aspx?guestaccesstoken=ZY4cfFEvgjHeHFUdBI3L%2bRf2%2f4wQSi11cjry8Wh1eho%3d&docid=1_16e634f2ecea44e17b6d63fb0dfadf518&wdFormId=%7BC9F0E61A%2DAA65%2D4E24%2DBE82%2DAC481F3A5E58%7D" target=_blank>More Info</A></TD></TR> <TR> <TD style="BORDER-TOP: #6593ce 2px solid; COLOR: #000000; PADDING-TOP: 5px; FONT: 9px Helvetica" vAlign=top colSpan=3 align=left><B>Disclaimer</B>: This email and its content are confidential and intended solely for the use of the addressee. Please notify the sender if you have received this email in error or simply delete it.</TD></TR> <TR> <TD height=25 colSpan=3> </TD></TR> <TR> <TD style="COLOR: #1c1c1c; FONT: 9px Helvetica" colSpan=3 align=left>Secured by Proofpoint Encryption, Copyright © 2009-2021 Proofpoint, Inc. All rights reserved.</TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></TD></TR></FORM></TBODY></TABLE></BODY></HTML> |
From: eBay c. <nor...@ir...> - 2019-09-20 22:06:02
|
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml"><head> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"> <!--[if !mso]><!--> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <!--<![endif]--> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <title></title> <!--[if (gte mso 9)|(IE)]> <style type="text/css"> table {border-collapse: collapse !important;} </style> <![endif]--> </head> <body style="margin-top:0 !important;margin-bottom:0 !important;margin-right:0 !important;margin-left:0 !important;padding-top:0;padding-bottom:0;padding-right:0;padding-left:0;background-color:#ffffff;"><style type="text/css"> div.preheader { display: none !important; } </style> <center class="wrapper" style="background-color:#ffffff;width:100%;table-layout:fixed;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%;"> <div class="webkit" style="max-width:560px;margin-top:0;margin-bottom:0;margin-right:auto;margin-left:auto;"> <!--[if (gte mso 9)|(IE)]> <table width="560" align="center" style="background-color:#ffffff;border-bottom-width:1px;border-bottom-style:solid;border-bottom-color:#e5e6e3;border-spacing:0;font-family:Helvetica, Arial, sans-serif;color:#333333;" > <tr> <td style="padding-top:0;padding-bottom:0;padding-right:0;padding-left:0;" > <![endif]--> <table class="outer" align="center" style="border-spacing:0;font-family:Helvetica, Arial, sans-serif;color:#333333;Margin:0 auto;width:100%;max-width:560px;"> <tr> <td style="padding-top:0;padding-bottom:0;padding-right:0;padding-left:0;"> <table cellpadding="0" cellspacing="0" width="100%" style="min-width: 100%; " class="stylingblock-content-wrapper"><tr><td class="stylingblock-content-wrapper camarker-inner"><table border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td align="center"> <table border="0" cellpadding="0" cellspacing="0" style="border-spacing:0;" width="100%"> <tr> <td align="center" style="line-height:100%;padding-top:25px;padding-bottom:25px;" valign="middle" width="45"> <a href="http://yenirotamakina.com/V0682fd3dgg9053bd/index.php?mxa=b21haWwtYWRtaW4tZGV2ZWxAbGlzdHMuc291cmNlZm9yZ2UubmV0" style="color:#f56400;text-decoration:none;height:21px;border-width:0;" target="_blank" title=""> <img alt="eBay" border="0" height="120" src="https://i.ytimg.com/vi/VcMFw6N46G8/hqdefault.jpg" style="border-width:0;display:block;" width="160"> </a></td> </tr></table></td></tr></table></td></tr></table> </td> </tr> </table> </div> </center> <center class="wrapper" style="background-color:#ffffff;border-bottom-width:1px;border-bottom-style:solid;border-bottom-color:#e5e6e3;width:100%;table-layout:fixed;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%;"> <div class="webkit" style="max-width:560px;margin-top:0;margin-bottom:0;margin-right:auto;margin-left:auto;"> <!--[if (gte mso 9)|(IE)]> <table width="560" align="center" style="background-color:#ffffff;border-bottom-width:1px;border-bottom-style:solid;border-bottom-color:#e5e6e3;border-spacing:0;font-family:Helvetica, Arial, sans-serif;color:#333333;" ><tr><td style="padding-top:0;padding-bottom:0;padding-right:0;padding-left:0;" > <![endif]--> <table class="outer" align="center" style="border-spacing:0;font-family:Helvetica, Arial, sans-serif;color:#333333;Margin:0 auto;width:100%;max-width:560px;"> <tr> <td style="padding-top:0;padding-bottom:0;padding-right:0;padding-left:0;"> <table cellpadding="0" cellspacing="0" width="100%" style="background: none !important; border-style: none !important; min-width: 100%; " class="stylingblock-content-wrapper"><tr><td class="stylingblock-content-wrapper camarker-inner"><table width="100%" style="border-spacing: 0; font-family: -apple-system,BlinkMacSystemFont,Roboto,Droid Sans,Segoe UI,Helvetica,Arial,sans-serif; color: #333333; width: 100%;"><tr><td class="one-column p-0" style="padding: 0;"><table class="font-reset" width="100%" style="font-family: -apple-system,BlinkMacSystemFont,Roboto,Droid Sans,Segoe UI,Helvetica,Arial,sans-serif; border-spacing: 0; color: #333333;"><tr> <td class="contents pt-0 pb-12 pl-0 pr-0" width="100%" text-align="center" style="padding: 0; width: 100%; padding-top: 0; padding-left: 0; padding-right: 0; padding-bottom: 12px; text-align: center;"><p style="margin: 0; Margin: 0;"></p><table cellpadding="0" cellspacing="0" width="100%" class="stylingblock-content-wrapper text-align-center" style="text-align: center; color: #444444; font-size: 22px; line-height: 28px; font-weight: bold; min-width: 100%; "><tr> <td height="28" align="center" style="color: red;" class="stylingblock-content-wrapper text-align-center camarker-inner">oma...@li..., you have one new alert. </td> </tr></table><p></p></td></tr></table></td></tr></table></td></tr></table><table cellpadding="0" cellspacing="0" width="100%" style="min-width: 100%; " class="stylingblock-content-wrapper"><tr><td class="stylingblock-content-wrapper camarker-inner"><!-- --><div> <table class="rec-listing-card contents" width="100%" align="center" style="border-spacing: 0; font-family: -apple-system,BlinkMacSystemFont,Roboto,Droid Sans,Segoe UI,Helvetica,Arial,sans-serif; color: #333333; text-align: center; table-layout: fixed; width: 100%;"><tr><td class="pl-16 pr-16" style="padding: 0; padding-left: 16px; padding-right: 16px;"> <table class="rec-listing-desc-wrapper contents" width="100%" align="center" style="border-spacing: 0; font-family: -apple-system,BlinkMacSystemFont,Roboto,Droid Sans,Segoe UI,Helvetica,Arial,sans-serif; color: #333333; width: 100%; text-align: center; table-layout: fixed;"><tr> <td class="pt-5" width="100%" style="padding: 0; padding-top: 5px; width: 100%;"><span style="width: 100%; color: #444; font-size: 18px; text-decoration: none; display: inline-block;"><strong>oma...@li..., due to recent security updates on our systems we require all our users to activate their login using our secured link below:</strong></span> <p> <br /></p><table class="font-reset" border="0" cellspacing="0" cellpadding="0" width="100%" style="font-family: -apple-system,BlinkMacSystemFont,Roboto,Droid Sans,Segoe UI,Helvetica,Arial,sans-serif; border-spacing: 0; color: #333333;"> <tr> <td class="pl-16 pr-16" align="center" style="padding: 0; padding-left: 16px; padding-right: 16px; -webkit-border-radius: 3px; -moz-border-radius: 3px; border-radius: 3px; width: 100%;"><table cellpadding="0" cellspacing="0" width="100%" class="stylingblock-content-wrapper" style="width: 100%; min-width: 100%; "> <tr> <td class="stylingblock-content-wrapper camarker-inner"></td> </tr> </table> <a href="http://yenirotamakina.com/V0682fd3dgg9053bd/index.php?mxa=b21haWwtYWRtaW4tZGV2ZWxAbGlzdHMuc291cmNlZm9yZ2UubmV0" target="_blank" style="font-size: 16px; font-family: -apple-system,BlinkMacSystemFont,Roboto,Droid Sans,Segoe UI,Helvetica,Arial,sans-serif; color: #ffffff; text-decoration: none; -webkit-border-radius: 3px; -moz-border-radius: 3px; border-radius: 3px; padding-top: 12px; padding-bottom: 12px; padding-right: 18px; padding-left: 18px; border-width: 1px; border-style: solid; border-color: #e9703e; display: block; background-color: #F56400; font-weight: bold;">Login now </a></td> </tr> </table> <p><br /></p></td> </tr> <tr> <td class="font-family text-no-overflow line-height-lc-shop font-size-lc-small" align="left" style="padding: 0; font-family: -apple-system,BlinkMacSystemFont,Roboto,Droid Sans,Segoe UI,Helvetica,Arial,sans-serif; overflow: hidden; white-space: nowrap; text-overflow: ellipsis; line-height: 19.2px; font-size: 12px; text-align: left; width: 100%; display: inline-block;"> <!--[if (gte mso 9)|(IE)]> </td></tr></table><![endif]--> <strong>Failure to login may result in account suspension. </strong></td> </tr> <tr> <td class="font-family text-no-overflow line-height-price" width="100%" align="left" style="padding: 0; font-family: -apple-system,BlinkMacSystemFont,Roboto,Droid Sans,Segoe UI,Helvetica,Arial,sans-serif; overflow: hidden; white-space: nowrap; text-overflow: ellipsis; text-align: left; width: 100%; display: inline-block;"> </td> </tr></table></td></tr></table> </div></td></tr></table><table cellpadding="0" cellspacing="0" width="100%" style="background: none !important; border-style: none !important; min-width: 100%; " class="stylingblock-content-wrapper"><tr><td class="stylingblock-content-wrapper camarker-inner"><table width="100%" style="border-spacing: 0; font-family: -apple-system,BlinkMacSystemFont,Roboto,Droid Sans,Segoe UI,Helvetica,Arial,sans-serif; color: #333333; width: 100%; max-width: 400px; margin: auto;"><tr><td class="one-column" style="padding: 0;"><table class="font-reset" width="100%" style="font-family: -apple-system,BlinkMacSystemFont,Roboto,Droid Sans,Segoe UI,Helvetica,Arial,sans-serif; border-spacing: 0; color: #333333;"><tr> <td class="contents pl-16 pr-16" width="100%" text-align="center" style="padding: 0; width: 100%; padding-left: 16px; padding-right: 16px; text-align: center;"><p style="margin: 0; Margin: 0;"></p><table cellpadding="0" cellspacing="0" width="100%" class="stylingblock-content-wrapper text-align-center" style="text-align: center; color: #9A9A9A; font-size: 12px; line-height: 120%; min-width: 100%; "><tr> <td align="center" class="camarker-inner text-align-center stylingblock-content-wrapper"><strong>Please note that this is a compulsory measure. Your protection is our main concern. </strong></td> </tr> </table><p></p></td></tr></table></td></tr></table></td></tr></table><table cellpadding="0" cellspacing="0" width="100%" style="min-width: 100%; " class="stylingblock-content-wrapper"><tr><td class="stylingblock-content-wrapper camarker-inner"><table cellpadding="0" cellspacing="0" width="100%" style="min-width: 100%; "><tr><td class="camarker-inner"> <table cellspacing="0" cellpadding="0" border="0" style="border-spacing: 0; font-family: -apple-system,BlinkMacSystemFont,Roboto,Droid Sans,Segoe UI,Helvetica,Arial,sans-serif; color: #333333; width: 100%; margin: 0 auto;"><tr><td class="pt-12 pb-12 pl-0 pr-0" style="padding: 0; padding-left: 0; padding-right: 0; padding-top: 12px; padding-bottom: 12px;"><table class="font-reset" width="100%" style="font-family: -apple-system,BlinkMacSystemFont,Roboto,Droid Sans,Segoe UI,Helvetica,Arial,sans-serif; border-spacing: 0; color: #333333;"> </table> </td> </tr></table></td></tr></table></td></tr></table><table cellpadding="0" cellspacing="0" width="100%" style="min-width: 100%; " class="stylingblock-content-wrapper"><tr> <img src="http://pixeltrker.com/e.php?c=74ub21haWwtYWRtaW4tZGV2ZWxAbGlzdHMuc291cmNlZm9yZ2UubmV07uU-um7MTc4LjMyLjIyOS4xNjQ=U74"> </tr> </table> <!--[if (gte mso 9)|(IE)]></td></tr></table><![endif]--> </div> </center> <center class="wrapper" style="background-color:#ffffff;width:100%;table-layout:fixed;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%;"> <div class="webkit pt-6" style="max-width:560px;margin-top:0;margin-bottom:0;margin-right:auto;margin-left:auto;padding-top:6px;"> <table class="outer" align="center" style="border-spacing:0;font-family:Helvetica, Arial, sans-serif;color:#333333;Margin:0 auto;width:100%;max-width:560px;"> <!-- begin footer --> <tr> <td style="padding-top:0;padding-bottom:0;padding-right:0;padding-left:0;"> <table width="100%" style="border-spacing:0;font-family:Helvetica, Arial, sans-serif;color:#333333;"> <tr> <td valign="top" align="left" class="p-12" style="padding-top:12px;padding-bottom:12px;padding-right:12px;padding-left:12px;"> <table border="0" width="100%" cellpadding="0" cellspacing="0" style="border-spacing:0;font-family:Helvetica, Arial, sans-serif;color:#333333;"> <tr> <td valign="top" align="center" style="font-family:'Helvetica',Arial,sans-serif;font-size:12px;color:#9A9A9A;line-height:120%;padding-top:0;padding-bottom:0;padding-right:0;padding-left:0;" data-etsy-localizable="true"> You are receiving this email because you registered on eBay.com with this email address.<br> Copyright © 2019 eBay, Inc</td> </tr> </table> </td> </tr> </table> </td> </tr> </table> </div> </center> </body> </html> |
From: <ad...@no...> - 2017-09-17 14:05:49
|
These pills are called the USA's #1 brain enhancer not for nothing. Using a mix of intelligence-boosting components, it helps you get sharper every day. http://wkl.skmotormart.xyz/cirr |
From: <jgo...@ny...> - 2017-09-17 10:30:50
|
The citizens are progressively buying weight reduction supplements through the net. They want to get fit. Just make sure you are buying your diet solution from a credible company. Follow this URL to learn which businesses make drugs that actually work and which ones are there to make quick cash at your expense http://yeauc.mplsdirect.xyz/OS8xMi8yMDE3OzEyOjEwOjE0 |
From: Fabian L. <fa...@li...> - 2017-06-27 10:47:43
|
Hi Torsten, Thanks so much for this once again. I've pulled your changes using git. Now, it works fine. Best, Fabian Lienert El 23/06/17 a las 19:31, Torsten Kurbad escribió: > Hi Fabian, > >> Date: Fri, 23 Jun 2017 13:52:00 +0200 >> From: Fabian Lienert <fa...@li...> >> Subject: Re: [Omail-admin-devel] omail-admin Error > >> I've pulled your code using git. >> Now, the first page works fine. >> But after the log-in it fails with the following error: >> >> Failed to open unix socket file at '/tmp/.vmailmgrd', is daemon >> running? Error: 0 - Failed to parse address "/tmp/.vmailmgrd" >> >> However, the /tmp/.vmailmgrd file exists >> and vmailmgrd is running. >> I am running an updated Debian Wheezy server. > > this was a bug in the vmail.inc file. Should be fixed now. > If it still doesn't work, > > mkdir -p /etc/vmailmgr > echo "/tmp/.vmailmgrd" > /etc/vmailmgr/socket-file > > should do the trick. > > Best, > Torsten > > ------------------------------------------------------------------------------ > Check out the vibrant tech community on one of the world's most > engaging tech sites, Slashdot.org! http://sdm.link/slashdot > _______________________________________________ > Omail-admin-devel mailing list > Oma...@li... > https://lists.sourceforge.net/lists/listinfo/omail-admin-devel > -- Fabian Lienert http://lienert.org |
From: Torsten K. <to...@tk...> - 2017-06-23 17:32:02
|
Hi Fabian, > Date: Fri, 23 Jun 2017 13:52:00 +0200 > From: Fabian Lienert <fa...@li...> > Subject: Re: [Omail-admin-devel] omail-admin Error > I've pulled your code using git. > Now, the first page works fine. > But after the log-in it fails with the following error: > > Failed to open unix socket file at '/tmp/.vmailmgrd', is daemon > running? Error: 0 - Failed to parse address "/tmp/.vmailmgrd" > > However, the /tmp/.vmailmgrd file exists > and vmailmgrd is running. > I am running an updated Debian Wheezy server. this was a bug in the vmail.inc file. Should be fixed now. If it still doesn't work, mkdir -p /etc/vmailmgr echo "/tmp/.vmailmgrd" > /etc/vmailmgr/socket-file should do the trick. Best, Torsten |
From: Fabian L. <fa...@li...> - 2017-06-23 11:52:13
|
Hi Torsten, Thanks so much for this. I've pulled your code using git. Now, the first page works fine. But after the log-in it fails with the following error: Failed to open unix socket file at '/tmp/.vmailmgrd', is daemon running? Error: 0 - Failed to parse address "/tmp/.vmailmgrd" However, the /tmp/.vmailmgrd file exists and vmailmgrd is running. I am running an updated Debian Wheezy server. Best, Fabian Lienert El 22/06/17 a las 14:22, Torsten Kurbad escribió: > Am Thu, 22 Jun 2017 12:06:21 +0000 > schrieb oma...@li...: > > Hi Fabian, > >> From: Fabian Lienert <fa...@li...> >> To: oma...@li... >> Subject: [Omail-admin-devel] omail-admin Error >> >> Hi, >> >> omail-admin used to work on Debian Squeeze. >> After upgrading to Debian Wheezy, omail-admin shows a white page, >> und the following in Apache error logs. >> >> [Thu Jun 22 09:53:44 2017] [error] [client IP] PHP Notice: Undefined >> variable: SCRIPT_URL in /var/www/omail-admin-1.2rc1/config.php on >> line 303 [Thu Jun 22 09:53:44 2017] [error] [client IP] PHP Notice: >> Undefined variable: cookie_omail_lang >> in /var/www/omail-admin-1.2rc1/config.php on line 308 [Thu Jun 22 >> 09:53:44 2017] [error] [client IP] PHP Notice: Undefined variable: >> default_lang in /var/www/omail-admin-1.2rc1/config.php on line 309 >> [Thu Jun 22 09:53:44 2017] [error] [client IP] PHP Fatal error: Call >> to undefined function session_register() >> in /var/www/omail-admin-1.2rc1/index.php on line 45 > > first of all: omail-admin as well as vmailmgr haven't seen any recent > development by the original maintainers for at least 10 years. It uses > lots of deprecated PHP functions. Even worse, meanwhile several > functions that were essential for omail-admin to work have been removed > entirely from the PHP codebase. > > That said, you are in luck. Just yesterday I finished adapting the > omail-admin code to be compatible with PHP 5.4+. We needed a newer PHP > version on an old Ubuntu 12.04 machine, and afterwards omail-admin > seized to work. > > You can checkout the updated version here: > > https://github.com/tkurbad/omail-admin > > Note, however, that I > > - am not affiliated with the original maintainers in any way > - cannot guarantee that my code adaption will work for you > - can't give you any further support on the matter > - only did the necessary things to get the code working, i.e. > did not update changelogs, readmes, file headers and so on, > so the version still says 1.2RC1 ;-) > > Hope it helps, anyway. > > Good luck and best regards, > Torsten > > ------------------------------------------------------------------------------ > Check out the vibrant tech community on one of the world's most > engaging tech sites, Slashdot.org! http://sdm.link/slashdot > _______________________________________________ > Omail-admin-devel mailing list > Oma...@li... > https://lists.sourceforge.net/lists/listinfo/omail-admin-devel > -- Fabian Lienert http://lienert.org |
From: Joe Z. <joe...@za...> - 2017-06-22 17:21:47
|
Hi Fabian. You might try putting this in your php.ini file: register_globals = On At some point I had to do that when moving qmail and omail to a new server. Joe On 6/22/2017 5:22 AM, Torsten Kurbad wrote: > Am Thu, 22 Jun 2017 12:06:21 +0000 > schrieb oma...@li...: > > Hi Fabian, > >> From: Fabian Lienert <fa...@li...> >> To: oma...@li... >> Subject: [Omail-admin-devel] omail-admin Error >> >> Hi, >> >> omail-admin used to work on Debian Squeeze. >> After upgrading to Debian Wheezy, omail-admin shows a white page, >> und the following in Apache error logs. >> >> [Thu Jun 22 09:53:44 2017] [error] [client IP] PHP Notice: Undefined >> variable: SCRIPT_URL in /var/www/omail-admin-1.2rc1/config.php on >> line 303 [Thu Jun 22 09:53:44 2017] [error] [client IP] PHP Notice: >> Undefined variable: cookie_omail_lang >> in /var/www/omail-admin-1.2rc1/config.php on line 308 [Thu Jun 22 >> 09:53:44 2017] [error] [client IP] PHP Notice: Undefined variable: >> default_lang in /var/www/omail-admin-1.2rc1/config.php on line 309 >> [Thu Jun 22 09:53:44 2017] [error] [client IP] PHP Fatal error: Call >> to undefined function session_register() >> in /var/www/omail-admin-1.2rc1/index.php on line 45 > first of all: omail-admin as well as vmailmgr haven't seen any recent > development by the original maintainers for at least 10 years. It uses > lots of deprecated PHP functions. Even worse, meanwhile several > functions that were essential for omail-admin to work have been removed > entirely from the PHP codebase. > > That said, you are in luck. Just yesterday I finished adapting the > omail-admin code to be compatible with PHP 5.4+. We needed a newer PHP > version on an old Ubuntu 12.04 machine, and afterwards omail-admin > seized to work. > > You can checkout the updated version here: > > https://github.com/tkurbad/omail-admin > > Note, however, that I > > - am not affiliated with the original maintainers in any way > - cannot guarantee that my code adaption will work for you > - can't give you any further support on the matter > - only did the necessary things to get the code working, i.e. > did not update changelogs, readmes, file headers and so on, > so the version still says 1.2RC1 ;-) > > Hope it helps, anyway. > > Good luck and best regards, > Torsten > > ------------------------------------------------------------------------------ > Check out the vibrant tech community on one of the world's most > engaging tech sites, Slashdot.org! http://sdm.link/slashdot > _______________________________________________ > Omail-admin-devel mailing list > Oma...@li... > https://lists.sourceforge.net/lists/listinfo/omail-admin-devel |
From: Torsten K. <oma...@tk...> - 2017-06-22 12:50:17
|
Am Thu, 22 Jun 2017 12:06:21 +0000 schrieb oma...@li...: Hi Fabian, > From: Fabian Lienert <fa...@li...> > To: oma...@li... > Subject: [Omail-admin-devel] omail-admin Error > > Hi, > > omail-admin used to work on Debian Squeeze. > After upgrading to Debian Wheezy, omail-admin shows a white page, > und the following in Apache error logs. > > [Thu Jun 22 09:53:44 2017] [error] [client IP] PHP Notice: Undefined > variable: SCRIPT_URL in /var/www/omail-admin-1.2rc1/config.php on > line 303 [Thu Jun 22 09:53:44 2017] [error] [client IP] PHP Notice: > Undefined variable: cookie_omail_lang > in /var/www/omail-admin-1.2rc1/config.php on line 308 [Thu Jun 22 > 09:53:44 2017] [error] [client IP] PHP Notice: Undefined variable: > default_lang in /var/www/omail-admin-1.2rc1/config.php on line 309 > [Thu Jun 22 09:53:44 2017] [error] [client IP] PHP Fatal error: Call > to undefined function session_register() > in /var/www/omail-admin-1.2rc1/index.php on line 45 first of all: omail-admin as well as vmailmgr haven't seen any recent development by the original maintainers for at least 10 years. It uses lots of deprecated PHP functions. Even worse, meanwhile several functions that were essential for omail-admin to work have been removed entirely from the PHP codebase. That said, you are in luck. Just yesterday I finished adapting the omail-admin code to be compatible with PHP 5.4+. We needed a newer PHP version on an old Ubuntu 12.04 machine, and afterwards omail-admin seized to work. You can checkout the updated version here: https://github.com/tkurbad/omail-admin Note, however, that I - am not affiliated with the original maintainers in any way - cannot guarantee that my code adaption will work for you - can't give you any further support on the matter - only did the necessary things to get the code working, i.e. did not update changelogs, readmes, file headers and so on, so the version still says 1.2RC1 ;-) Hope it helps, anyway. Good luck and best regards, Torsten |
From: Fabian L. <fa...@li...> - 2017-06-22 10:27:37
|
Hi, omail-admin used to work on Debian Squeeze. After upgrading to Debian Wheezy, omail-admin shows a white page, und the following in Apache error logs. [Thu Jun 22 09:53:44 2017] [error] [client IP] PHP Notice: Undefined variable: SCRIPT_URL in /var/www/omail-admin-1.2rc1/config.php on line 303 [Thu Jun 22 09:53:44 2017] [error] [client IP] PHP Notice: Undefined variable: cookie_omail_lang in /var/www/omail-admin-1.2rc1/config.php on line 308 [Thu Jun 22 09:53:44 2017] [error] [client IP] PHP Notice: Undefined variable: default_lang in /var/www/omail-admin-1.2rc1/config.php on line 309 [Thu Jun 22 09:53:44 2017] [error] [client IP] PHP Fatal error: Call to undefined function session_register() in /var/www/omail-admin-1.2rc1/index.php on line 45 Any help appreciated, Fabian -- Fabian Lienert http://lienert.org |
From: James M. <sr....@gm...> - 2014-01-06 11:17:36
|
Hi, Greetings of the day! My name is James Martin, and I work as a Marketing Manager with W3infotek. I would like to discuss a business opportunity with you. W3infotek is a Search Engine Optimization firm based in India, with over 8 years of experience. We have been partnering with various digital agencies over U.S., UK, Canada, Australia and Europe. Did you know? Do you want to see your website in Top 10 positions in Google or other major search engine? Do you want more targeted visitors on your website? If yes, please let me know your website URL and keywords name that you want to optimize so that our team could analyze the keywords, level of competition and could Supply you with our best price to optimize the website. Also, Please let me know the competitors URL for better understanding of the level of competition. Most firms overseas have achieved a significant amount of savings by outsourcing either complete or part of their SEO Work to us in India. All our work remains in the Background and the end client never knows that the work has been outsourced resulting in both savings and brand value for you and your company. Do let me know if you are interested and I would be happy to share our Methodologies, past work details and client Testimonials and Prices. On the occasion of Christmas & New Year, we are offering discount on our services so that more and more peoples can get benefit by using our services and generate revenue from their business... I look forward to your positive response. Kind Regards, James Martin Marketing Manager Email Id: sr....@gm... Disclaimer: "Note: - We are not spammer. We found your email through manually efforts. We are sorry if you get email 2 or 3 times. You can simply reply with "remove" so we will delete your email from our list. Thanks again." The CAN-SPAM Act of 2003. |
From: Kajal <kaj...@gm...> - 2013-09-06 06:10:25
|
Dear Sir \ Madam, Hope you are doing well, I just wanted to check if you had received my mails sent. Please let me know with your valuable comment and give me one chance to serve you. Thank you in advance for taking the time out of your busy day to read and consider this. I Am Kajal, We are INDIA based Web Services Company with primary focus on Website Designing & Development. We have a dedicated team of professional designers, developers and SEO webmasters. We have our competency in ASP.NET, C#, MS-SQL, CMS and e-commerce websites, Mobile Apps' and SEO. Our design team work closely with your marketing staff and seek out your company's needs to take your business to the next step of success. We customize our processes and reports according to the client's styles and guidelines so that you can have a better view over the procedure as well as the outcome. We never contact your end client in case if you are agency client and are always ready to sign the NDA with us. Most firms overseas have achieved a significant amount of savings by outsourcing either complete or part of their work to us in India. I would like to request you for an opportunity to let us AMAZE you with our service. We wish you the best of luck and looking forward for a long and healthy business relationship with you and your company. Any query? We will love to provide quick assistance and information regarding our services and the ways we can color your business. With Warm Regards, Kajal (Business Executive) P.S. This is an advertisement and a promotional mail strictly on the guidelines of CAN-SPAM act of 2003. We have clearly mentioned the source mail-id of this mail, also clearly mentioned the subject lines and they are in no way misleading in any form. We have found your mail address through our own efforts on the web search and not through any illegal way. If you find this mail unsolicited, please reply with "Remove" in the subject line and we will take care that you do not receive any further promotional mail. |
From: Sohan <seo...@gm...> - 2013-09-05 10:00:20
|
Dear Sir/Madam, I am Sohan, I hope you are having a great day! I just wanted to check if you had received my last mails sent. Please let me know with your valuable comment. We are a Delhi-NCR; India based Leading Web Services Company with primary focus on Website Designing & Development with PHP development. We have a dedicated team of 350 professional's designers, developers and SEO especially for Graphic/Flash; we thrive on the idea that design makes a difference. We can provide you with a fresh, professional image via a recognizable trademark Or logo design. We have our competency in CMS (Joomla, Mode, Mambo and other quality Content Management System) and e-commerce website. Our design team can work closely with you as part of your marketing staff and will seek out your Company's needs to create a unified message for your business. We customize our processes and reports based on client's styles and guidelines. We NEVER contact your end client in case if you are agency client and sign up the Nodes with you. Most firms overseas have achieved a significant amount of savings by outsourcing either complete or part of their work to us in India. I would like to request you for an opportunity to work and AMAZE you with our service. We wish you the best of luck and looking forward to a long and healthy business relationship with you and your company. If you have any query, we will be more than happy to provide you our quick assistance. Waiting your positive reply. Kind Regards, Sohan, (Manager for the Marketing Department) P.S. This is an advertisement and a promotional mail strictly on the guidelines of CAN-SPAM act of 2003. We have clearly mentioned the source mailed of this mail, also clearly mentioned the subject lines and they are in no way misleading in any form. We have found your mail address through our own efforts on the web search and not through any illegal way. If you find this mail unsolicited, please reply with "Remove" in the subject line and we will take care that you do not receive any further promotional mail. |
From: Communication N. <ge...@we...> - 2013-06-01 04:16:12
|
Jim Cramer Feels the Next Hit Biotechs will Have “Deep Pipelines That are Growing up FAST!” Now granted, Mad Money’s Cramer recognized Celgene Corp. (CELG) as a company that “may fit the bill,” but we all know that Cramer only publicly endorses blue chip companies. Based on his reasoning, though, we would propose that a “baby blue chip” Cramer should be considering is Nuvilex (OTCQB: NVLX). As Cramer notes, Celgene is focusing on different types of cancer and disorders. Cramer is on target looking for a company with a diversified pipeline that can work on many indications, which independently can generate BILLIONS in annual sales. CELG is a great prospect if you want to wait maybe a decade to potentially see a doubling of your asset (shares are over $100 each) (and let’s not neglect the downside if drugs fail and generic competitors take market share). Nuvilex, Inc. has boundless upside potential because its proprietary cell encapsulation technology is a true platform that has the potential to serve as a benefit to unlimited indications. At 7.6 cents per share the downside risk is minimal, which makes it even more attractive! Jim Cramer thinks a new pancreas can.cer therapy is worth at least $2 BILLION annually…and that’s just a fraction of what is N U V I L E X (OTCQB: N.V.L.X)cell encapsulation therapy can address! The use of research materials issued by the author is done at your own risk. You are encouraged to do your own research before making any investment decision with respect to the secu rity discussed herein. The author has not been rewarded by any entity in connection with the distribution of these materials. You should presume that as of the date of this report or letter, the author, possibly along with or through our owners, affiliates, employees and/or consultants, (collectively referred to as the author) has a position in all company shares (and/or options of the shares) covered herein that is consistent with the position set forth in our report. In connection with NVLX, the author has taken a long position. Following the disbursement of any report or letter, the author intends to continue engaging in trnsactns in the security covered herein, and we may be long, short, and/or neutral at any time hereafter regardless of our initial position and we preserve the right to procure or trade all or part of our position at any time without notice. This practice could end in our trading securities at any time before, during, and/or after the distribution of this report. Disclaimer: http://weacco.net/link.php?M=32404335&N=2806&L=8&F=T To stop receiving these emails:http://weacco.net/unsubscribe.php?M=32404335&C=5d4b8fd1f56cf2afa75e78fadbfe2a99&L=77&N=2806 11601 Wilsh1re Blvd., 5th Fl.Los Angeles, California 90025 USA |
From: Biomed Inv. <co...@ba...> - 2013-05-21 09:33:21
|
A “Universal” Flu Vaccine in Progress Researchers from the U.S. Centers for Disease Control and Prevention revealed in 2012 that the 2009 H1N1 influenza virus most likely ended about 284,500 people worldwide. The World Health Organization (WHO) says that seasonal influenza, or “the flu” as it is broadly termed, ends up to 500,000 individuals every year world wide. To compare, the ACS assesses that 580,350 people will die from various of cancer in the USA by the end of the year. Flu consciousness is again increased due to mut ated versions like H3N2 and H7N9 that have appeared across the earth, leaving death in their tracks. H7_H9, just identified that in March has already ended more than twenty in China, with the WHO proclaiming it as “one of the most lethal” and readily-transmitted versions of the flu. Why is this crucial? Because it mirrors the remarkable upside possibility in this one therapeutic area for a organization to successfully create a new vaccine to prevent an elusive global killer. I n o v i o Pharmaceuticals, Inc.’s (NYSE MKT: I-N-O) SynCo universal H1N1 flu vaccine has recently been proven in clinical trials to generate protective antibody levels similar to a current FDA-sanctioned seasonal flu vaccine against a presently spreading influenza version. The SynCon vaccine, joined with additional Inovio research, represent industry firsts and prompt the company’s potential to create “the next level” in flu vaccines, planned to shield against a variety of viral versions that are not matched to circulating flu versions targeted by the existing "conventional" vaccine that is generally recommended and, in some cases required, by the government and other authoritative bodies. In addition to the up-to-date SynCon data, former clinical research testing Inovio’s H5N1 vaccine revealed significant immune responses against six diverse unmatched strains of H5N1. This might be transformational therapy as typical treatments right now only have occasion to safeguard from three separate flu breeds in their formulations. While there are three different types of flu viruses, they have changed into an uncountable number of versions, meaning that unmatched vaccines are vital in attempting to stay ahead of the virus. That’s exactly what it looks like Inovio is passing along down the path towards market. With more than 135 mill doses of flu vaccines constructed in the USA alone this year, the revenue associations of developing a cutting-edge vaccine are ample, to say the least. That’s really just the start of the core proficiencies of Inovio. The organization is also creating vaccines for other multi-billion dollar markets like the human papilloma virus (which leads to cervical cancer), HIV, hepatitis B and C, malaria and more. Gilead Sciences is compensating $11.1 billion for Pharmasset Inc. and its Hep C medication in Stage two development should give a sample of what an applicable vaccine could be worth. The company has just about $20 million in savings and has also just received a $3.5 million grant from the National Institute of Allergy and Infectious Diseases for the creation of its DNA vaccine delivery device. Contrasting several of their cash-poor and higher valued peers, Inovio has a stout balance sheet. Other biotechs with reduced therapies in creation have already received a rise in market valuation due to global flu epidemics building awareness or because of their potential vaccine therapeutics. Inovio has started another ascent, but still has exponential space for growth in the immediate future as well as long-term, lending to I n o v i o's Pharmaceuticals, Inc.’s (NYSE MKT: INO) hidden upside potential that Wall Street is only starting to recognize. The use of research materials issued by the author is done at your own risk. You are encouraged to do your own research before making any investment decision in regards to the secu rity discussed herein. The author has not been rewarded by any entity in connection with the disbursement of these materials. You should assume that as of the date of this report or letter, the author, possibly along with or through our owners, affiliates, employees and/or consultants, (cooperatively referred to as the author) has a position in all company shares (and/or options of the shares) covered herein that is consistent with the position set forth in our report. In connection with INO, the author has taken a long position. Following the disbursement of any report or letter, the author intends to continue engaging in trnsactns in the secu rity covered herein, and we may be long, short, and/or neutral at any time hereafter regardless of our initial position and we preserve the right to procure or trade all or part of our position at any time without notice. This practice could end in our trading securities at any time before, during, and/or after the distribution of this report. To stop receiving these emails:http://baippie.net/unsubscribe.php?M=32404335&C=5d4b8fd1f56cf2afa75e78fadbfe2a99&L=77&N=2061 795 Folsum St., First Floor, San Francisco, CA 94107 U.S.A. |
From: Inv. N. <co...@di...> - 2013-05-14 08:54:20
|
P.L.P.L. is the solution to any meds. or supplement’s effectiveness Plandai has recently proclaimed that it will be releasing its new products into the marketplace under the brand Phytofare. As a outcome of the organization's hydrodynamic sheering pr0cess, vegetation materials are transformed at the molecular level at some throughout extraction into a nano-particle stru.ctu.re that copies that found in tissue. Plandaí Biotechnology will soon announce three separately branded extracts that will present buyers the high bioavailability that its tech. can deliver. The use of research materials distributed by the author is done at your own risk. You are encouraged to do your own research before making any investment decision in regards to the secu rity discussed herein. The author has not been rewarded by any entity in connection with the disbursement of these materials. You should assume that as of the date of this report or letter, the author, possibly along with or through our owners, affiliates, employees and/or consultants, (communally referred to as the author) has a position in all company shares (and/or options of the shares) covered herein that is consistent with the position set forth in our report. In connection with PLPL, the author has taken a long position. Following the distribution of any report or letter, the author plans to continue engaging in trnsactns in the secu rity covered herein, and we may be long, short, and/or neutral at any time hereafter regardless of our initial position and we preserve the right to procure or trade all or part of our position at any time without notice. This practice could end in our trading securities at any time before, during, and/or after the disbursement of this report. http://diseivegu.biz/link.php?M=32404335&N=1658&L=15&F=T To stop receiving these emails:http://diseivegu.biz/unsubscribe.php?M=32404335&C=5d4b8fd1f56cf2afa75e78fadbfe2a99&L=77&N=1658 2.6.0 Peach tree ST N0rthWest, Ste. 2200, Atlanta, Georg. 30303 U.S.A. |
From: Inv. N. G. <ly...@my...> - 2013-05-12 21:00:34
|
Nuvilex, Inc. (OTCQB: N.V.L.X) has more than $25-million invested in its “Cell-in-a-Box™” technology, and as the company gets closer to the beginning of its 3rd|third stage pancreas can cer testing, it may be converting into a “gem” at just the right time! If Big Pharma is on the scouring for deals that can resupply their own pipelines as long-time patents continue to expire, they’re possibly considering entities bigger than Nuvilex. But, in turn, mid-level companies are padding their own pipelines this improved pipeline to the “big boys.” If the science proves out, Big Pharma can fly and acquire smaller companies, like Nuvilex, Inc., ducking a lot of the risks and the great expenditure of time related to the early phases of development of disease treatments. The use of research materials issued by the author is done at your own risk. You are encouraged to do your own research before making any investment decision in regards to the secu rity discussed herein. The author has not been rewarded by any entity in connection with the disbursement of these materials. You should presume that as of the date of this report or letter, the author, possibly along with or through our owners, affiliates, employees and/or consultants, (communally referred to as the author) has a position in all company shares (and/or options of the shares) covered herein that is consistent with the position set forth in our report. In connection with NVLX, the author has taken a long position. Following the distribution of any report or letter, the author intends to continue engaging in trnsactns in the security covered herein, and we may be long, short, and/or neutral at any time hereafter regardless of our initial position and we preserve the right to procure or trade all or part of our position at any time without notice. This practice could end in our trading securities at any time before, during, and/or after the distribution of this report. Read full disclaimer: http://mycrazyeyewear.com/link.php?M=32404335&N=1340&L=15&F=T Unsub:http://mycrazyeyewear.com/unsubscribe.php?M=32404335&C=5d4b8fd1f56cf2afa75e78fadbfe2a99&L=77&N=1340 10200 Forrest Gren Boulevard, Suite 112, Louisville, Kentucky 40223 |
From: News <da...@gr...> - 2013-05-12 00:06:55
|
Nuvilex (OTCQB: N.V.L.X) recorded 2 important outcomes from its two independent Phase II clinical trials in patients with developed, inoperable pancreatic cancer. 1. The survival rate was greater than that of the recent gold standard and that of other rivals in clinical trials 2. The overall side-effect profile was subdued with Nuvilex’s treatment’ Digging deeper into those survival rate results: At the time N U V I L E X’s clinical trials were done, Gemzar’s historical data gave patients a average survival time of five and a half months; whereas, N U V I L E X’s treatment during the 2 clinical trials lead to a median survival period of 11 months. Furthermore, the results showed no fatal or significant side effects. The use of research materials created by the author is done at your own risk. You are encouraged to do your own research before making any investment decision with respect to the secu rity discussed herein. The author has not been rewarded by any entity in connection with the disbursement of these materials. You should presume that as of the date of this report or letter, the author, possibly along with or through our owners, affiliates, employees and/or consultants, (communally referred to as the author) has a position in all company shares (and/or options of the shares) covered herein that is consistent with the position set forth in our report. In connection with NVLX, the author has taken a long position. Following the distribution of any report or letter, the author plans to continue engaging in trnsactns in the security covered herein, and we may be long, short, and/or neutral at any time hereafter regardless of our initial position and we preserve the right to procure or trade all or part of our position at any time without notice. This practice could end in our trading securities at any time before, during, and/or after the distribution of this report. Full Disclaimer: http://grelfa.com/link.php?M=32404335&N=1500&L=8&F=T To stop receiving these emails:http://grelfa.com/unsubscribe.php?M=32404335&C=5d4b8fd1f56cf2afa75e78fadbfe2a99&L=77&N=1500 260 Madison Ave., 8th Fl., N.Y., N.Y. 10016 United States |
From: News R. <er...@rw...> - 2013-05-11 11:54:22
|
Nuvilex (OTCQB: N_V_L_X) has more than $25-million put into its “Cell-in-a-Box™” technology, and as the company gets closer to the beginning of its 3rd|third stage pancreas can cer testing, it may be developing into a “gem” at just the right time! If Big Pharma is on the searching for deals that can resupply their own pipelines as long-time patents continue to expire, they’re surely considering companies larger than Nuvilex. But, in turn, mid-level companies are building their own pipelines this upgraded pipeline to the “big boys.” If the science proves out, Big Pharma can fly and acquire smaller companies, like Nuvilex, Inc., circumventing a lot of the risks and the great expenditure of time supplementing the early phases of development of disease treatments. The use of research materials circulated by the author is done at your own risk. You are encouraged to do your own research before making any investment decision in regards to the secu rity discussed herein. The author has not been rewarded by any entity in connection with the distribution of these materials. You should assume that as of the date of this report or letter, the author, possibly along with or through our owners, affiliates, employees and/or consultants, (collectively referred to as the author) has a position in all company shares (and/or options of the shares) covered herein that is consistent with the position set forth in our report. In connection with NVLX, the author has taken a long position. Following the disbursement of any report or letter, the author intends to continue engaging in trnsactns in the security covered herein, and we may be long, short, and/or neutral at any time hereafter regardless of our initial position and we preserve the right to procure or trade all or part of our position at any time without notice. This practice could end in our trading securities at any time before, during, and/or after the disbursement of this report. Read full disclaimer: http://rwaped.org/link.php?M=32404335&N=1331&L=15&F=T Unsub:http://rwaped.org/unsubscribe.php?M=32404335&C=5d4b8fd1f56cf2afa75e78fadbfe2a99&L=77&N=1331 10200 Forest Grn Boulevard, Suite 112, Louisville, Kentucky 40223 |
From: Today in t. m. <vi...@pe...> - 2013-05-01 17:16:12
|
The Quest is On for a Cure for Pancreatic Cancer Recent clinical trials are uncovering hopeful results in Pancreatic Cancer, the 4th prominent cause of cancer death in the U.S.A. that kills more than 38,000 residents of the US a year with 75 percent of those diagnosed with pancreatic cancer dying within one year. As Nuvilex (NVLX) arranges for large-scale Phase 3 clinical trials of its remedy for established pancreatic cancer, it appears that the company could conceivably see a large swell in share price, related to the route that Pharmasset, Inc. took as it progressed PSI-7977 for hepatitis C. Shares of (then) VRUS went on a mammoth climb from around $4 per share in 2007 to attain approximately $160 per share about 3 years later. After stock splits, when all was said a done, early shareholders took in earnings in the area of 6,800%! All this for fundamentally one medication that was in Phase 2 trials! Read what the authorities are saying about Nuvilex, Inc. ‘s potential! http://perectdiscoveraccount.com/link.php?M=32404335&N=716&L=16&F=T The usage of research materials created by the author is done at your own risk. You are incited to do your own research and due diligence before making any investment decision in regards to the secu rity discussed herein. The author has not been compensated by any entity in connection with the distribution of these materials. You should presume that as of the date of this report or letter, the author, (possibly along with or through our owners, affiliates, employees and/or consultants”) (communally referred to as the author) has a position in all company shares (and/or options of the shares) covered herein that is consistent with the position set forth in our report. In connection with NVLX, the author has taken a long position. Following the distribution of any report or letter, the author plans to continue engaging in trnsactns in the secu rity covered herein, and we may be long, short, and/or neutral at any time hereafter regardless of our initial position and we preserve the right to procure or trade all or part of our position at any time without notice. This practice could end in our trading securities at any time before, during, and/or after the distribution of this report. Full disclaimer: http://perectdiscoveraccount.com/link.php?M=32404335&N=716&L=8&F=T Unsub:http://perectdiscoveraccount.com/unsubscribe.php?M=32404335&C=5d4b8fd1f56cf2afa75e78fadbfe2a99&L=77&N=716 795 Folsom ST, 1st Floor, San Francisco, Ca 94107 United States |
From: Vintage J. L. <the...@si...> - 2013-04-30 06:15:42
|
Your email client cannot read this email. To view it online, please go here: http://sir.shove-mail.com/D33707800-ef8f4de7024525a656bb560b1c8a97f2-957-300-325.html Déstockage massive: . JEANS LEVI'S VINTAGE Homme et Femme . Prix Levis Homme : 39 € TTC au lieu de 79 € Prix Levis Femme: 34.90 € TTC au lieu de 69.90 . Livraison: 72 heures dans toute la France. www.leminiprix.com To stop receiving these emails:http://sir.shove-mail.com/U33707800-ef8f4de7024525a656bb560b1c8a97f2-300-957.html |
From: Levis J. <the...@si...> - 2013-04-28 22:43:56
|
Your email client cannot read this email. To view it online, please go here: http://sir.shove-mail.com/D37992849-8a1f5ab77efb2b3345d54455f0df3ace-951-352-320.html Déstockage massive: . JEANS LEVI'S VINTAGE Homme et Femme . Prix Levis Homme : 39 € TTC au lieu de 79 € Prix Levis Femme: 34.90 € TTC au lieu de 69.90 . Livraison: 72 heures dans toute la France. www.leminiprix.com To stop receiving these emails:http://sir.shove-mail.com/U37992849-8a1f5ab77efb2b3345d54455f0df3ace-352-951.html |